Moneycontrol
HomeNewsBusinessCoronavirus pandemic | Hero Moto Corp assures dealers to take care of unsold BS-IV stock
Trending Topics

Coronavirus pandemic | Hero Moto Corp assures dealers to take care of unsold BS-IV stock

According to industry sources, around 1,000 Hero MotoCorp dealers are holding close to 1.5 lakh BS-IV stock with them.

March 28, 2020 / 21:22 IST
Story continues below Advertisement

The country's largest two-wheeler maker Hero MotoCorp on March 28 assured its dealers to take care of their unsold BS IV stock. Addressing around 1,000 company dealers at an interactive digital town hall on Saturday morning, Hero MotoCorp Chairman Pawan Munjal assured dealers that the company will not let them suffer due to the unsold BS IV inventory.

"I stay firm on my own personal commitment and that of the organisation – to ensure the welfare and well being of each one of you," Munjal told dealers.

Story continues below Advertisement

A company dealer who attended the town hall confirmed the assurance given by the chairman.

The company, however, did not issue a formal note on the meeting and neither offered a comment on the event.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show